Skip to main content
. 2016 Mar 27;2016:3582380. doi: 10.1155/2016/3582380

Figure 2.

Figure 2

Genome editing in cardiovascular disease modeling with induced pluripotent stem cells. Patient-specific induced pluripotent stem cells are corrected using genome editing tools to create a panel of isogenic iPSC lines that are differentiated into cardiomyocytes for disease modeling, drug discovery and screening, and cell therapy.